치과용 생체 재료 시장 : 제품 유형, 용도, 최종 사용자, 유통 채널별 예측(2026-2032년)

The Dental Biomaterials Market is projected to grow by USD 17.06 billion at a CAGR of 7.27% by 2032.

Dental Biomaterials Executive Summary

The dental biomaterials market is advancing from a materials-supply category into a strategic enabler of restorative, prosthetic, implant, orthodontic, and regenerative dentistry. Demand is supported by a large and persistent oral disease burden: the World Health Organization reports that oral diseases affect nearly 3.5 billion people globally, and untreated dental caries in permanent teeth remains among the most prevalent health conditions worldwide.

For manufacturers, growth is being shaped by the shift toward bioactive restorative materials, high-strength dental ceramics, zirconia, resin composites, bonding agents, bone graft substitutes, membranes, implant surfaces, and CAD/CAM-compatible polymers. Competitive advantage increasingly depends on clinical evidence, biocompatibility, workflow integration, regulatory readiness, and the ability to serve both chairside and laboratory-based digital dentistry.

Transformative Shifts in the Dental Biomaterials Landscape

The landscape is being reshaped by digital dentistry, minimally invasive treatment, and patient demand for esthetic, durable, and metal-free restorations. CAD/CAM milling, 3D printing, intraoral scanning, and guided implant workflows are increasing the need for materials with predictable mechanical properties, validated curing behavior, shade stability, radiopacity, wear resistance, and compatibility with digital manufacturing.

At the same time, biomaterial innovation is moving beyond passive replacement toward functional performance. Bioactive glass, calcium silicate-based materials, antibacterial coatings, hydrophilic implant surfaces, and resorbable regenerative materials are gaining attention as clinicians seek better tissue integration, reduced failure risk, and improved long-term outcomes. Regulatory scrutiny under frameworks such as the U.S. FDA medical device pathway, EU Medical Device Regulation, and ISO 10993 biocompatibility standards is making documentation quality a core differentiator.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is creating cumulative impact across product discovery, production quality, clinical planning, and post-market surveillance. In R&D, AI-assisted modeling can help screen material formulations, predict mechanical behavior, optimize filler loading, assess structure-property relationships, and accelerate hypothesis generation before physical testing. In manufacturing, machine vision and analytics support defect detection, lot traceability, and process control for ceramics, composites, implant components, and printed dental devices.

In clinical and laboratory workflows, AI is strengthening case planning through radiographic analysis, implant positioning support, margin detection, restoration design assistance, occlusal assessment, and outcome monitoring. The strongest opportunities are expected where AI is paired with validated datasets, regulatory-compliant quality systems, and transparent human oversight, because dental biomaterials still require rigorous evidence for safety, biocompatibility, wear, fatigue, adhesion, and intraoral performance.

Key Regional Insights

Asia-Pacific is becoming a high-priority region as China, India, Japan, South Korea, Australia, and ASEAN markets expand access to restorative dentistry, implantology, orthodontics, and digital dental laboratories. The region combines large patient populations, rising private dental spending, and strong manufacturing capacity, particularly in ceramics, implants, CAD/CAM materials, and 3D-printable resins. Japan, South Korea, and Australia show strong adoption of precision prosthetics and evidence-based dental products, while China, India, and Southeast Asia are advancing through private clinic growth, expanding dental education, and broader availability of digital workflows.

North America remains a premium innovation and adoption hub, supported by advanced dental service organizations, specialist implant practices, university research, FDA-regulated product pathways, and high penetration of intraoral scanning, CAD/CAM dentistry, and guided surgery. Europe continues to be shaped by strong clinical standards, CE marking requirements under the EU MDR, and demand for esthetic and biocompatible materials, while Germany, Italy, France, Spain, and the United Kingdom remain influential in prosthodontics, dental technology, implant dentistry, and laboratory-based restorative workflows.

Latin America is progressing through private clinic growth, expanding implant dentistry, and demand for cost-effective restorative materials, with Brazil and Mexico serving as major anchors due to dental education capacity, urban dental service networks, and regional manufacturing strengths. The Middle East, especially GCC markets, is investing in premium dental care, esthetic dentistry, implantology, and medical tourism, while Africa presents a longer-term access opportunity driven by urbanization, public health needs, increasing awareness of oral disease, and the gradual expansion of private dental infrastructure.

Key Group Insights

ASEAN offers a combined manufacturing and demand opportunity as Indonesia, Thailand, Vietnam, Malaysia, Singapore, and the Philippines expand dental care capacity and digital laboratory adoption. Singapore and Thailand are notable for higher-value dental services and medical tourism, while larger population markets are increasing demand for affordable composites, adhesives, prosthetic materials, preventive solutions, and CAD/CAM-compatible restoratives that can support broader access to care.

The GCC is positioned toward premium dentistry, implantology, esthetic restorations, and imported high-quality biomaterials, supported by healthcare investment, private specialty clinics, and demand for advanced dental technologies. The European Union remains central for regulatory credibility and advanced dental technology, where MDR compliance, clinical evidence, post-market surveillance, traceability, and substantiated sustainability claims increasingly influence supplier selection.

BRICS markets combine scale and manufacturing potential, with China, India, and Brazil particularly important for localized production, dental laboratory expansion, and wider availability of restorative and implant solutions. G7 countries represent high-value demand for clinically validated biomaterials, advanced ceramics, regenerative products, implant surface technologies, and AI-enabled digital workflows. NATO markets overlap with many mature dental systems where supply resilience, cybersecurity in digital dentistry, product traceability, and trusted quality systems are becoming procurement priorities.

Key Country Insights

The United States leads in premium adoption of implants, clear aligner ecosystems, digital dentistry, and FDA-cleared dental materials, while Canada shows steady demand supported by an aging population and expanded public dental coverage initiatives intended to improve access for eligible residents. Mexico and Brazil are important Latin American markets, with Brazil standing out for dental education, implant adoption, specialist training, and domestic manufacturing capabilities, while Mexico benefits from private dental care networks and cross-border dental service demand.

In Europe, the United Kingdom, Germany, France, Italy, and Spain remain central to high-quality restorative and prosthetic dentistry. Germany is especially influential in precision dental engineering, CAD/CAM systems, ceramics, and regulatory-grade manufacturing, while France supports strong demand for restorative and implant materials through established dental care infrastructure. Italy and Spain maintain strong dental laboratory, prosthodontic, and esthetic dentistry ecosystems, and Russia continues to present demand for restorative and prosthetic materials, though supply conditions remain more sensitive to geopolitical and trade constraints.

China and India provide major long-term opportunity due to population scale, expanding private dental care, growing dental education capacity, and rapid adoption of intraoral scanning, milling, and 3D printing in urban centers. Japan and South Korea are advanced markets for precision prosthetics, implants, ceramics, and technology-enabled dentistry, with South Korea also recognized for implant manufacturing strength and export-oriented dental technology. Australia remains a stable, premium market with high clinical standards, strong uptake of evidence-based dental products, and consistent demand for restorative, implant, orthodontic, and preventive dental materials.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize clinically validated material platforms that align with digital dentistry, including CAD/CAM ceramics, printable resins, bioactive restoratives, regenerative scaffolds, bone graft substitutes, membranes, adhesives, and implant surface technologies. Product claims should be supported by biocompatibility, fatigue, wear, bond strength, radiopacity, cytotoxicity, aging, sterilization compatibility, and long-term performance data where applicable.

Manufacturers should localize portfolio strategy by region, balancing premium innovation for North America, Europe, Japan, South Korea, Australia, and GCC markets with cost-effective, reliable solutions for India, ASEAN, Latin America, and Africa. Leaders should also strengthen regulatory intelligence, build AI-ready data infrastructure, improve supply chain traceability, partner with dental schools and large clinical networks, and invest in sustainable packaging and material stewardship without overstating environmental claims.

Research Methodology

This executive summary is based on secondary research, regulatory review, clinical-market interpretation, and triangulation of publicly available evidence from authoritative sources, including the World Health Organization, national dental and medical device regulators, ISO standards, peer-reviewed dental materials literature, public health agencies, and recognized industry disclosures.

The methodology emphasizes validated indicators such as oral disease burden, demographic aging, dental procedure trends, regulatory requirements, digital dentistry adoption, product approval pathways, quality management expectations, clinical evidence standards, and regional healthcare investment. Insights are synthesized to support strategic decision-making while avoiding unsupported market-size claims, market share references, or speculative performance statements.

Conclusion

Dental biomaterials are entering a new phase defined by bioactivity, digital compatibility, esthetic performance, and evidence-based differentiation. The category is no longer driven only by replacement materials; it is increasingly linked to precision treatment planning, regenerative outcomes, minimally invasive care, and integrated digital workflows across clinics and laboratories.

Organizations that combine material science, clinical validation, regulatory excellence, AI-enabled quality systems, and region-specific commercialization are best positioned to capture demand. The strongest opportunities will belong to suppliers that can prove safety, durability, usability, biocompatibility, and measurable value for clinicians, laboratories, payers, and patients.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Definition
• 1.3. Market Segmentation & Coverage
• 1.4. Years Considered for the Study
• 1.5. Currency Considered for the Study
• 1.6. Language Considered for the Study
• 1.7. Key Stakeholders

2. Research Methodology

• 2.1. Introduction
• 2.2. Research Design
  • 2.2.1. Primary Research
  • 2.2.2. Secondary Research
• 2.3. Research Framework
  • 2.3.1. Qualitative Analysis
  • 2.3.2. Quantitative Analysis
• 2.4. Market Size Estimation
  • 2.4.1. Top-Down Approach
  • 2.4.2. Bottom-Up Approach
• 2.5. Data Triangulation
• 2.6. Research Outcomes
• 2.7. Research Assumptions
• 2.8. Research Limitations

3. Executive Summary

• 3.1. Introduction
• 3.2. CXO Perspective
• 3.3. Market Size & Growth Trends
• 3.4. Market Share Analysis, 2025
• 3.5. FPNV Positioning Matrix, 2025
• 3.6. New Revenue Opportunities
• 3.7. Next-Generation Business Models
• 3.8. Industry Roadmap

4. Market Overview

• 4.1. Introduction
• 4.2. Industry Ecosystem & Value Chain Analysis
  • 4.2.1. Supply-Side Analysis
  • 4.2.2. Demand-Side Analysis
  • 4.2.3. Stakeholder Analysis
• 4.3. Market Dynamics
  • 4.3.1. Key Drivers
  • 4.3.2. Key Restraints
  • 4.3.3. Key Opportunities
  • 4.3.4. Key Challenges
• 4.4. Porter's Five Forces Analysis
• 4.5. PESTLE Analysis
• 4.6. Market Outlook
  • 4.6.1. Near-Term Market Outlook (0-2 Years)
  • 4.6.2. Medium-Term Market Outlook (3-5 Years)
  • 4.6.3. Long-Term Market Outlook (5-10 Years)
• 4.7. Go-to-Market Strategy

5. Market Insights

• 5.1. Consumer Insights & End-User Perspective
• 5.2. Consumer Experience Benchmarking
• 5.3. Opportunity Mapping
• 5.4. Distribution Channel Analysis
• 5.5. Pricing Trend Analysis
• 5.6. Regulatory Compliance & Standards Framework
• 5.7. ESG & Sustainability Analysis
• 5.8. Disruption & Risk Scenarios
• 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Dental Biomaterials Market, by Product Type

• 7.1. Ceramics Biomaterials
  • 7.1.1. Alumina
  • 7.1.2. Glass Ceramics
  • 7.1.3. Zirconia
• 7.2. Composites Biomaterials
  • 7.2.1. Bulk Fill
  • 7.2.2. Hybrid
  • 7.2.3. Microfilled
  • 7.2.4. Nanofilled
• 7.3. Metallic Biomaterials
  • 7.3.1. Cobalt-Chromium Alloys
  • 7.3.2. Gold Alloys
  • 7.3.3. Stainless Steel
  • 7.3.4. Titanium & Alloys
• 7.4. Polymeric Biomaterials
  • 7.4.1. Polyetheretherketone (PEEK)
  • 7.4.2. Polymethyl Methacrylate (PMMA)
  • 7.4.3. Polyvinyl Siloxane (PVS)
  • 7.4.4. Polyether (PE)
• 7.5. Natural Biomaterials
  • 7.5.1. Protein-Based
  • 7.5.2. Polysaccharide-Based

8. Dental Biomaterials Market, by Application

• 8.1. Implantology
  • 8.1.1. Dental Implants
  • 8.1.2. Abutments
• 8.2. Orthodontics
  • 8.2.1. Aligners
  • 8.2.2. Arch Wires
  • 8.2.3. Brackets
• 8.3. Periodontics
  • 8.3.1. Barrier Membranes
  • 8.3.2. Bone Grafts
  • 8.3.3. Growth Factors
• 8.4. Prosthetics
  • 8.4.1. Complete Dentures
  • 8.4.2. Partial Dentures
• 8.5. Restorative
  • 8.5.1. Bridges
  • 8.5.2. Crowns
  • 8.5.3. Fillings
  • 8.5.4. Inlays & Onlays
• 8.6. Endodontics
  • 8.6.1. Gutta Percha Points
  • 8.6.2. Irrigants & Disinfectants
  • 8.6.3. Sealants

9. Dental Biomaterials Market, by End User

• 9.1. Hospitals & Dental Clinics
• 9.2. Dental Laboratories & Research Institutes
• 9.3. Dental Product Manufacturers

10. Dental Biomaterials Market, by Distribution Channel

• 10.1. Offline
• 10.2. Online

11. Dental Biomaterials Market, by Region

• 11.1. Asia-Pacific
• 11.2. North America
• 11.3. Latin America
• 11.4. Europe
• 11.5. Middle East
• 11.6. Africa

12. Dental Biomaterials Market, by Group

• 12.1. ASEAN
• 12.2. GCC
• 12.3. European Union
• 12.4. BRICS
• 12.5. G7
• 12.6. NATO

13. Dental Biomaterials Market, by Country

• 13.1. United States
• 13.2. Canada
• 13.3. Mexico
• 13.4. Brazil
• 13.5. United Kingdom
• 13.6. Germany
• 13.7. France
• 13.8. Russia
• 13.9. Italy
• 13.10. Spain
• 13.11. China
• 13.12. India
• 13.13. Japan
• 13.14. Australia
• 13.15. South Korea

14. Competitive Landscape

• 14.1. Market Concentration Analysis, 2025
  • 14.1.1. Concentration Ratio (CR)
  • 14.1.2. Herfindahl Hirschman Index (HHI)
• 14.2. Recent Developments & Impact Analysis, 2025
• 14.3. Product Portfolio Analysis, 2025
• 14.4. Benchmarking Analysis, 2025

15. Company Profiles

• 15.1. 3M Company
• 15.2. BEGO GmbH & Co. KG
• 15.3. Bioloren S.r.l.
• 15.4. Bisco, Inc.
• 15.5. Brasseler USA
• 15.6. CAM Bioceramics
• 15.7. Carpenter Technology Corporation
• 15.8. COLTENE Holding AG
• 15.9. Den-Mat Holdings, LLC
• 15.10. Dentsply Sirona Inc.
• 15.11. DSM-Firmenich AG
• 15.12. Envista Holdings Corporation
• 15.13. GC CORPORATION
• 15.14. Geistlich Pharma AG
• 15.15. Henry Schein, Inc.
• 15.16. Ivoclar Vivadent AG
• 15.17. Keystone Dental Group
• 15.18. KURARAY CO., LTD.
• 15.19. Medtronic plc
• 15.20. Mitsui Chemicals, Inc.
• 15.21. Septodont Holding
• 15.22. SHOFU INC.
• 15.23. Straumann Group
• 15.24. Victrex Manufacturing Limited
• 15.25. VITA Zahnfabrik
• 15.26. VOCO GmbH
• 15.27. Young Innovations, Inc.
• 15.28. ZimVie Inc.